DB15848InvestigationalVaccines
Gam-COVID-Vac was created by Gamaleya Research Institute of Epidemiology and MIcrobiology in Russia. The vaccine candidate is a heterologous COVID-19 vaccine containing two components, recombinant adenovirus type 26 (rAd26) vector... The vaccine is offered in both a frozen (Gam-COVID-Vac) and freeze-dried formulation (lyophilizate; Gam-COVID-Vac Lyo).
- Also known as
- Gam-COVID-Vac Lyo · Sputnik V
- Code names
- Gam-COVID-Vac
What you can answer from here — as of September 18, 2020
Which companies are running trials of Gam-COVID-Vac, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account